Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9560277 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Treating Schizophrenia by Correcting Abnormal Brain Development
Condition: Schizophrenia
Interventions: Drug: Tiagabine;   Drug: Placebo

Indicates status has not been verified in more than two years